Becton Dickinson (BDX) Cash from Investing Activities (2009 - 2026)

Becton Dickinson's (BDX) quarterly Cash from Investing Activities came in at -$139.0 million in Q1 2026, down 4.51% year-on-year from -$145.6 million in Q1 2025, and up 24.04% on a QoQ basis from -$183.0 million in Q4 2025.

Becton Dickinson (BDX) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has 18 years of Cash from Investing Activities data on file, last reported at -$139.0 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 4.51% year-over-year to -$139.0 million in Q1 2026; TTM through Mar 2026 was -$1.2 billion, a 70.85% increase from a year earlier, with the FY2025 full-year figure at -$818.0 million, up 85.17% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$139.0 million, up from -$183.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for BDX reached as high as $204.0 million in Q4 2024 and fell as low as -$3.9 billion in Q3 2024.
  • Historically, Cash from Investing Activities has averaged -$582.8 million across 5 years, with a median of -$288.0 million in 2024.
  • On a YoY basis, Cash from Investing Activities climbed as much as 187.55% in 2024 and fell as far as 2973.72% in 2024.
  • Year by year, Cash from Investing Activities stood at -$291.0 million in 2022, then gained by 19.93% to -$233.0 million in 2023, then soared by 187.55% to $204.0 million in 2024, then tumbled by 189.71% to -$183.0 million in 2025, then rose by 24.04% to -$139.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$139.0 million in Q1 2026, -$183.0 million in Q4 2025, and -$494.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -218.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -26.60 Mn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -139.00 Mn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -96.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -58.03 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -43.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -90.00 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -77.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -131.58 Mn
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn -133.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -139.00 Mn
Mar 31, 2026 -139.00 Mn
Dec 31, 2025 -183.00 Mn
Dec 31, 2025 -183.00 Mn
Sep 30, 2025 -494.00 Mn
Sep 30, 2025 -494.00 Mn
Jun 30, 2025 -395.00 Mn
Jun 30, 2025 -395.00 Mn
Mar 31, 2025 -133.00 Mn
Mar 31, 2025 -133.00 Mn
Dec 31, 2024 204.00 Mn
Dec 31, 2024 204.00 Mn
Sep 30, 2024 -3.94 Bn
Sep 30, 2024 -3.94 Bn
Jun 30, 2024 -288.00 Mn
Jun 30, 2024 -288.00 Mn
Mar 31, 2024 -1.06 Bn
Mar 31, 2024 -1.06 Bn
Dec 31, 2023 -233.00 Mn
Dec 31, 2023 -233.00 Mn